Soner CANKAYA, Derya ÇIRAKOĞLU, Alper CİRAKLİ, Havva ERDEM, Erdal UZUN

Claudin-5 (tight junction) expression level changes in achilles tendon healing

Aim: This study aimed to reveal the relationship between changes in Claudin-5 expression and the duration of healing in Achillestendon injury.Material and Methods: 18 Achilles tendons of Wistar-Albino rats were used in the study. Rats were divided into 3 groups as 6 ratsin each group, group 1; sham group, group 2; tendon repair group (sacrificed after 3 weeks), group 3; tendon repair group (sacrificedafter 6 weeks). Immunohistochemically, the tendons were stained with Claudin-5 and the degree of staining with light microscopewas rated between 0 and 3. The obtained scores were compared with Kruskal Wallis test and Posthoc analysis.Results: The scores were 0.5 ± 1 (0-1) in group 1.1 ± 1 (1-2) in group 2 and 1.5 ± 1 (1-2) in group 3. A statistically significantdifference was found between the groups (p = 0.026). In the posthoc analyzes, there was a significant difference between group 1and 3, but there was no significant difference between groups 1 and 2 and between groups 2 and 3.Conclusion: The expression of claudins is regulated by many factors, including hormones, various cytokines, and epithelialmesenchymaltransition-related transcription factors. In this study, the increase in the expression of Claudin-5 was noticed inproportion to the progress of primary wound healing. This relationship may be a part of the repair mechanism. The role of claudinlevels in intercellular passage is crucial for function as it is important for cell signaling. Achilles tendon healing can be attributed toa laboratory parameter such as claudin. This can help to understand the recovery rate and can help early return to work or sport.We believe that as a laboratory parameter Claudin-5 may be useful in the evaluation of tendon healing.

PDF

___

1. Krause G, Winkler L, Mueller SL, et al. Structure and function of claudins. Biochim Biophys Acta 2008;1778:631-45.
2. Cereijido M, Contreras RG, Shoshani L, et al. Tight junction and polarity interaction in the transporting epithelial phenotype. Biochim Biophys Acta 2008;1778:770-93.
3. Gonzalez-Mariscal L, Betanzos A, Nava Pet al. Tight junction proteins. Prog Biophys Mol Biol 2003;81:1-44.
4. Laukoetter MG, Nava P, Nusrat A. Role of the intestinal barrier in inflammatory bowel disease. World J Gastroenterol 2008;14:401-7.
5. Schill KE. master’s examination committee: devor st, rafael-fortney ja. oxygen consumption, muscle fibrosis, and oxidative stress in the mdx mouse: influence of treadmill running. presented in partial fulfillment of the requirements for the degree master of science in the graduate school of the ohio state university (Thesis) 2014.
6. Stone RC, Pastar I, Ojeh N, et al. Epithelial-mesenchymal transition in tissue repair and fibrosis. Cell Tissue Res 2016;365:495-506.
7. Lee B, Kang HY, Lee DO, et al. Claudin-1, -2, -4, and -5: comparison of expression levels and distribution in equine tissues. J Vet Sci 2016;17:445-51.
8. Günzel D, Yu AS. Claudins and the modulation of tight junction permeability. Physiol Rev 2013;93:525-69.
9. Furuse M, Fujita K, Hiiragi T, et al. Claudin-1 and -2: novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin. J Cell Biol 1998;141:1539-50.
10. Morita K, Sasaki H, Furuse M, et al. Endothelial claudin: claudin-5/TMVCF constitutes tight junction strands in endothelial cells. J Cell Biol 1999;147:185-94.
11. Tsukita S, Furuse M, Itoh M. Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol 2001;2:285-93.
12. Koczor CA, Lee EK, Torres RA, Boyd A, Vega JD, Uppal K, et all. Detection of differentially methylated gene promoters in failing and nonfailing human left ventricle myocardium using computation analysis. Physiol Genomics. 2013;45:597-605.
13. Rahner C, Mitic LL, Anderson JM. Heterogeneity in expression and subcellular localization of claudins 2, 3, 4, and 5 in the rat liver, pancreas, and gut. Gastroenterology. 2001;120:411-22.
14. Jiang N, Wang B, Chen A, et al. Operative versus nonoperative treatment for acute achilles tendon rupture: a meta-analysis based on current evidence. Int Orthop 2012;36:765-73.
15. Follak N, Ganzer D, Merk H. The utility of gait analysis in the rehabilitation of patients after surgical treatment of Achilles tendon rupture. Eur J Orthop Surg Traumatol 2002;12:90-5.
16. Soroceanu A, Sidhwa F, Aarabi S, et al. Surgical versus nonsurgical treatment of acute Achilles tendon rupture: a meta-analysis of randomized trials. J Bone Joint Surg Am 2012;94:2136-43.
17. Yüksel EP, Ilkaya F, Yildiz L, et al. Effects of paroxetine an cutaneous wound healing in healthy and diabetic rats. Adv Skin Wound Care 2014;27:216-21.
18. Immonen JA, Zagon IS, McLaughlin PJ. Topical naltrexone as treatment for type 2 diabetic cutaneous wounds. Adv Wound Care 2014;3:419-27.
19. Wu X, Alberico S, Saidu E, et al. Organic light emitting diode improves diabetic cutaneous wound healing in rats. Wound Rep Reg 2015;23:104-14.
20. Gonzalez JE, DiGeronimo RJ, Arthur DE, et al. Remodeling of the TJs during recovery from exposure to hydrogen peroxide in kidney epithelial cells. Free Radical Biology Med 2009;47:1561-9.
21. D’Souza T, Sherman-Baust CA, Poosala S, et al. Age-related changes of claudin expression in mouse liver, kidney, and pancreas. J Gerontol A Biol Sci Med Sci 2009;64:1146-53.
22. Delfin DA, Xu Y, Schill KE, et al. Sustaining cardiac claudin-5 levels prevents functional hallmarks of cardiomyopathy in a muscular dystrophy mouse model. Mol Ther 2012;20:1378- 83.
23. Swager SA, Delfín DA, Rastogi N, et al. Claudin-5 levels are reduced from multiple cell types in human failing hearts and are associated with mislocalization of ephrin-B1. Cardiovasc Pathol 2015;24:160-7.
24. Camilleri M, Madsen K, Spiller R, et al. Intestinal barrier function in health and gastrointestinal disease. Neurogastroenterol Motil. 2012;24:503-12.